Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

TNG961

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T217526 Copy Product Info
🥰Excellent
TNG961 is a potent, highly selective, CRBN-dependent HBS1L (GSPT3) molecular chaperone inhibitor. By degrading HBS1L, TNG961 specifically disrupts protein homeostasis in FOCAD-deficient cancer cells, thereby inducing growth inhibition and cell death. TNG961 can be used in studies of FOCAD-deficient tumors.
TNG961
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$1968-10 weeks8-10 weeks
5 mg$4488-10 weeks8-10 weeks
25 mg$9878-10 weeks8-10 weeks
100 mg$2,2808-10 weeks8-10 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
TNG961 is a potent, highly selective, CRBN-dependent HBS1L (GSPT3) molecular chaperone inhibitor. By degrading HBS1L, TNG961 specifically disrupts protein homeostasis in FOCAD-deficient cancer cells, thereby inducing growth inhibition and cell death. TNG961 can be used in studies of FOCAD-deficient tumors.
In vitro
TNG961 selectively kills FOCAD-deficient cancer cells, inducing translational stalling, endoplasmic reticulum stress, and activation of the unfolded protein response. [1]
In vitro experiments indicate that TNG961 causes a dose-dependent decrease in HBS1L protein levels, thereby disrupting the PELO domain involved in ribosomal rescue. TNG961 exhibits pan-proteomic selectivity for HBS1L; Western blot analysis shows no change in SALL4 protein levels.[2]
In vivo
Oral administration of TNG961 induces dose-dependent regression of FOCAD-deficient tumors and retains potent activity against FOCAD-deficient tumors resistant to PRMT5 inhibitors. [1]
In a FOCAD-deficient xenograft model, TNG961 (oral) dose-dependently degrades HBS1L and induces PELO protein instability, leading to tumor arrest or regression across multiple lineages.[2]
Chemical Properties
Molecular Weight539.57
FormulaC28H24F3N3O3S
SmilesO=C([C@H](CC1)C2=CC3=CC=CC(NC(NC(C)(C)C4=CC5=C(C=C(C(F)(F)F)C=C5)S4)=O)=C3C=C2)NC1=O
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Keywords

Related Tags: TNG961 chemical structure | TNG961 in vivo | TNG961 in vitro | TNG961 formula | TNG961 molecular weight